Performance of magnetic resonance elastography and diffusion-weighted imaging for the staging of hepatic fibrosis: A meta-analysis
Authors:
- 1 July 2012
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 56 (1) , 239-247
Abstract
A meta-analysis was performed to assess and compare the accuracies of magnetic resonance elastography (MRE) and diffusion-weighted imaging (DWI) for the staging of hepatic fibrosis. Online journal databases and a manual search from January 2000 to May 2011 were used. We identified 41 studies, but only 14 met the criteria to perform a meta-analysis assessing MRE (five trials) or DWI (10 trials). Fibrosis was categorized by redistribution into five stages according to histopathological description. A bivariate binomial model was used to combine the sensitivity and specificity and their 95% confidence intervals (CIs), from which diagnostic odds ratio (DOR), positive likelihood ratio (PLR), negative likelihood ratio (NLR), and summary receiver operating characteristic (sROC) were derived to indicate the diagnostic accuracy of imaging modalities. With MRE, the sensitivity, specificity, DOR, PLR, NLR, and area under sROC curve (with 95% CIs) for staging F0 ˜ F1 versus F2 ˜ F4 and F0 ˜ F2 versus F3 ˜ F4 were 0.94 (0.81-0.98), 0.95 (0.87-0.98), 20 (7-57), 0.06 (0.02-0.22), 317 (55-1,796), 0.98 (0.97-0.99) and 0.92 (0.85-0.96), 0.96 (0.91-0.98), 21 (10-45), 0.08 (0.04-0.16), 251 (103-609), and 0.98 (0.96-0.99), respectively; and with DWI, these values were 0.77 (0.71-0.82), 0.78 (0.69-0.85), 3 (2-5), 0.30 (0.22-0.40), 12 (6-21), 0.83 (0.79-0.86) and 0.72 (0.60-0.81), 0.84 (0.77-0.89), 5 (3-7), 0.34 (0.23-0.50), 13 (6-29), and 0.86 (0.83-0.89), respectively. A z test demonstrated that MRE had a significantly higher accuracy than DWI in those indicators (P < 0.05). Conclusion: MRE is more reliable for staging hepatic fibrosis, compared with DWI, with a high combination of sensitivity, specificity, likelihood ratios, DOR, and area under sROC curve. (HEPATOLOGY 2012;56:239–247)Keywords
Funding Information
- The Scientific Research Program of Shanghai Science and Technology Committee (09411962800)
This publication has 57 references indexed in Scilit:
- Invasive and non-invasive methods for the assessment of fibrosis and disease progression in chronic liver diseaseBest Practice & Research Clinical Gastroenterology, 2011
- Assessment of Fibrosis and Cirrhosis in Liver Biopsies: An UpdateSeminars in Liver Disease, 2011
- MR Imaging of activated hepatic stellate cells in liver injured by CCl4 of rats with integrin-targeted ultrasmall superparamagnetic iron oxideEuropean Radiology, 2010
- Diagnosis, management, and treatment of hepatitis C: An update # † ‡Hepatology, 2009
- Assessment of hepatitis C: non‐invasive fibrosis markers and/or liver biopsyLiver International, 2009
- Liver biopsyGastroentérologie Clinique Et Biologique, 2008
- Liver fibrosisBiochemical Journal, 2008
- Reversal of Hepatic Fibrosis — Fact or Fantasy?Hepatology, 2006
- HEPATIC FIBROSIS: Molecular Mechanisms and Drug TargetsAnnual Review of Pharmacology and Toxicology, 2005
- Evaluation of Liver Fibrosis: A Concise ReviewAmerican Journal of Gastroenterology, 2004